Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy – results from a double-blind, randomized, and placebo-controlled trial

Farnia, Vahid; Tatari, Faezeh; Alikhani, Mostafa; Yazdchi, Katayoun; Taghizadeh, Moshen; Bahmani, Dena Sadeghi; Karbasizadeh, Hassan; Holsboer‐Trachsler, Edith; Brand, Serge

doi:10.1016/j.jpsychires.2017.08.011

Cited by 14 publications

(26 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As shown in Figure 1 [21], and ArginMax was used for one [7], red clover (Trifoliumpratense) is used in one [8], Libifem (Trigonellafoenum-graecum) in one [10], Elaeagnus angustifolia in one [11]. Ginkgo biloba leaves were used in one study [16], saffron (Crocus sativus) was used in one [17], and Rosa damascena oil was used in two studies [18] [19].…”

Section: Resultsmentioning

confidence: 99%

“…Studies evaluating the efficacy on DIFSD were concerned with interventions using Ginko biloba [16], Saffron [17], and Rosa damascene [18] [19]. DIFSD was a result of antidepressant medication in three of the studies [16] [17] [18].…”

Section: Resultsmentioning

confidence: 99%

“…Rosa damascena oil (2 ml/day for 8 weeks) failed to increase sexual function when DIFSD was the result of antidepressant medication [18], but it increased FSFI with respect to placebo when DIFSD was due to methadone [19].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

The Use of Natural Products for the Treatment of Female Sexual Dysfunction: A Systematic Review of Randomized Clinical Trials

Jurado¹,

Jouda-Benazouz²,

Mendoza-Huertas³

et al. 2020

ASM

View full text Add to dashboard Cite

Female sexual dysfunction (FSD) affects 40% of the world's females, most of which are disorders linked to desire or interest/excitement. Whilst all types of therapy that attempt to improve female sexual desire have long been established, the results are contradictory. Objective: To analyze all available evidence to validate the effectiveness of natural therapies in the treatment of FSD. Method: The study was registered at http://www.prospero.org (CRD42019127700). We searched the Institute for Scientific Information Web of Knowledge, MEDLINE, Pubmed, Scopus and Cochrane databases for all articles published in peerreviewed journals in April 2019 (in any language). The PICOS standard is women with FSD; (intervention) of any type of Natural therapy; (outcome) primary outcome: frequency of changes, severity, and average mean scores on sexual symptoms measured with a validated instrument, secondary outcome: quality of life; (study design) and randomized clinical trial (RCT). Results: The literature search strategy identified 95 articles, 81 of which were excluded at the different search stages. Finally, we systematically reviewed 15 RCTs, 11 of which referred to primary FSD, and four of which analyzed women with drug-induced FSD (DFSD). Most of them analyzed hypoactive sexual desire disorder. Although differences related to placebo were found in most people, the majority of the studies are considered to be of poor quality and low external effectiveness. Conclusion: Although the quality of the evidence is not high, most natural product interventions appear to improve FSD, particularly hypoactive sexual desire disorders including those categorized as primary and drug-induced.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The Use of Natural Products for the Treatment of Female Sexual Dysfunction: A Systematic Review of Randomized Clinical Trials

Jurado¹,

Jouda-Benazouz²,

Mendoza-Huertas³

et al. 2020

ASM

View full text Add to dashboard Cite

show abstract

“…Due to the difference in terms of the pathophysiology of sexual dysfunction, the treatment option of sexual dysfunction in the OST population is different from the other population. Antidepressants such as bupropion and trazodone and herbal alternatives such as rosa Damascena and ginseng have been reported to significantly improve OST patients with sexual dysfunction [8,[22][23][24][25][26][27]. Although various clinical studies and reviews have explored the role of intervention for sexual dysfunction in many conditions, such as diabetes, stroke, and cancer population, the effectiveness and safety of sexual dysfunction intervention in the OST population has not been studied thoroughly [28][29][30].…”

Section: Ivyspringmentioning

confidence: 99%

Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis

2021

View full text Add to dashboard Cite

Sexual dysfunction is a common condition in the opioid substitution therapy (OST) population. We aimed to determine the efficacy and safety of treatment for sexual dysfunction in the OST population. We searched for interventional studies from Medline, PubMed, and Scopus. Three independent authors conducted a risk-of-bias assessment (RoB 2). A total of seven studies (five randomized-controlled trials, two quasi-experimental), including 473 patients with sexual dysfunction, were identified. Among these, three bupropion (n=207), one trazodone (n=75), two rosa Damascena (n=100), and one ginseng (n=91) studies had reported significantly improve various sexual functioning domains in both genders. In a meta-analysis, bupropion significantly increased male sexual function with standardized mean difference of 0.53; 95% confidence interval of 0.19-0.88; P < 0.01; I 2 =0. The adverse effects were minor for all agents, and no significant difference between treatment and placebo groups in randomized-controlled trials. These agents have a promising future as therapy for sexual dysfunction in the OST population. However, given the limited sample size and number of studies, further studies should be conducted to confirm the use of these agents.

show abstract

“…In addition, recently, it has been reported that Rosa damascena oil had an improvement effect on sexual function in patients under SSRI treatment, methadone treatment for opium use disorder. [67][68][69][70] Psychosocial approaches particularly cognitive-behavioral therapy (CBT) may be utilized in an antidepressant-induced sexual dysfunction. Whereas the CBT is widely used in a variety of psychiatric disorders, the limited number of investigations has been in antidepressant-associated sexual dysfunction.…”

Section: Management Of Ssri-induced Sexual Dysfunctionmentioning

confidence: 99%

<p>Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives</p>

Atmaca¹

2020

NDT

View full text Add to dashboard Cite

Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRIinduced sexual dysfunction and new perspectives in the management of this problem were reviewed.

show abstract

Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy – results from a double-blind, randomized, and placebo-controlled trial

Cited by 14 publications

References 34 publications

The Use of Natural Products for the Treatment of Female Sexual Dysfunction: A Systematic Review of Randomized Clinical Trials

The Use of Natural Products for the Treatment of Female Sexual Dysfunction: A Systematic Review of Randomized Clinical Trials

Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis

<p>Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives</p>

Contact Info

Product

Resources

About